Phase II Clinical Trial of Ixabepilone in Patients With Recurrent or Persistent Platinum- and Taxane-Resistant Ovarian or Primary Peritoneal Cancer: A Gynecologic Oncology Group Study

PURPOSE: Ixabepilone (BMS-247550) is a microtubule-stabilizing epothilone B analog with activity in taxane-resistant metastatic breast cancer. The Gynecologic Oncology Group conducted a phase II evaluation of the efficacy and safety of ixabepilone in patients with recurrent or persistent platinum- a...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: De Geest, Koen, Blessing, John A., Morris, Robert T., Yamada, S. Diane, Monk, Bradley J., Zweizig, Susan L., Matei, Daniela, Muller, Carolyn Y., Richards, William E.
Format: Artigo
Jezik:Inglês
Izdano: American Society of Clinical Oncology 2010
Teme:
Original Reports
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC2799230/
https://ncbi.nlm.nih.gov/pubmed/19917861
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2009.24.1455
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki